Abstract
To investigate whether ivermectin, a semi-synthetic derivative of a family of macrocyclic lactones could inhibit lipopolysaccharide (LPS)-induced inflammation in vivo and in vitro.
Users
Please
log in to take part in the discussion (add own reviews or comments).